|
NDUFS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14029999997989E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12279999999287E-05 |
| Normal-vs-Stage2 |
4.602600E-01 |
| Normal-vs-Stage3 |
6.08150000025454E-07 |
| Normal-vs-Stage4 |
1.34630000003799E-06 |
| Stage1-vs-Stage2 |
6.268400E-02 |
| Stage1-vs-Stage3 |
2.595400E-01 |
| Stage1-vs-Stage4 |
1.812000E-01 |
| Stage2-vs-Stage3 |
2.137900E-02 |
| Stage2-vs-Stage4 |
1.410450E-02 |
| Stage3-vs-Stage4 |
6.381200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.69249999962362E-07 |
| Normal-vs-AfricanAmerican |
1.387510E-02 |
| Normal-vs-Asian |
9.159300E-04 |
| Caucasian-vs-AfricanAmerican |
2.965600E-01 |
| Caucasian-vs-Asian |
7.996800E-01 |
| AfricanAmerican-vs-Asian |
5.031000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6076000000087E-06 |
| Normal-vs-Female |
1.75701999999278E-05 |
| Male-vs-Female |
1.133010E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.82049999999779E-05 |
| Normal-vs-Age(41-60Yrs) |
8.78130000048216E-07 |
| Normal-vs-Age(61-80Yrs) |
1.143860E-02 |
| Normal-vs-Age(81-100Yrs) |
1.858390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.233000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.999770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.737000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.779600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.682400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.896800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.087200E-01 |
| Classical-VS-Follicular |
4.688300E-02 |
| Classical-VS-Other |
1.068000E-01 |
| Classical-VS-Normal |
8.01250000015408E-07 |
| Tall-VS-Follicular |
8.894300E-02 |
| Tall-VS-Other |
7.386000E-02 |
| Tall-VS-Normal |
2.961700E-04 |
| Follicular-VS-Other |
2.580800E-03 |
| Follicular-VS-Normal |
8.587600E-02 |
| Other-VS-Normal |
2.767200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.42060000005462E-06 |
| Normal-vs-N1 |
1.08599999992798E-07 |
| N0-vs-N1 |
6.751500E-02 |
|
|
